Moderna Covid shots authorised for emergency use in Bangladesh

The Directorate General of Drug Administration on Tuesday night approved emergency use of Covid-19 vaccine Moderna in the country.

The regulator has given Emergency Use Authorisation (EUA) after all necessary examinations by the technical committee, a press release of DGDA said.

According to the DGDA, Moderna is the eighth vaccine to be given the EUA.

On June 15, DGDA approved emergency use of Johnson & Johnson's Covid-19 vaccine "Janssen" in Bangladesh.

On June 3, the Directorate General of Drug Administration (DGDA) approved the Chinese Covid-19 vaccine "CoronaVac", manufactured by Sinovac Life Sciences Company Limited.

On May 27, the DGDA approved emergency use of the Pfizer mRNA Covid-19 vaccine in the country.

Bangladesh has so far approved eight Covid-19 vaccines to control the deadly disease.

These vaccines are Covid-19 vaccine Moderna, Johnson & Johnson, "CoronaVac", manufactured by Sinovac Life Sciences Company Limited, Pfizer mRNA Covid-19 vaccine, Covishield produced by Serum Institute of India; Sputnik V manufactured by Generium Joint Stock Company of Russia, AstraZeneca manufactured by Sweden and Sinopharm produced by Beijing Institute of Biological Products Co Ltd of China.